Advertisement

 

 

Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges.

Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges.
Author Information (click to view)

Zash RM, Williams PL, Sibiude J, Lyall H, Kakkar F,


Zash RM, Williams PL, Sibiude J, Lyall H, Kakkar F, (click to view)

Zash RM, Williams PL, Sibiude J, Lyall H, Kakkar F,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Expert opinion on drug safety 2016 8 23()

Abstract
INTRODUCTION
The use of antiretroviral therapy (ART) in pregnancy to prevent vertical HIV transmission has been one of the most successful public health programs in the last decade. As a result, an unprecedented number of women are taking ART at conception and during pregnancy. Given few randomized studies evaluating safety of different ART regimens in pregnancy, ongoing drug safety surveillance is critical.

AREAS COVERED
This review aims to provide a rationale for ART drug safety surveillance, describe changing patterns of ART use and summarize current surveillance efforts in both low-resource and high-resource settings. Additionally, biostatistical approaches to and challenges in analysis of observational surveillance data are discussed.

EXPERT OPINION
The global landscape of ART use in pregnancy is rapidly increasing and evolving. Any increase in adverse effects of in-utero exposure to ART has the potential to reduce the impact of improvements in infant morbidity and mortality gained from decreased vertical HIV transmission. ART drug safety surveillance should therefore be a critical piece of programs to prevent mother to child transmission in both high- and low-resource settings. Current surveillance efforts could be strengthened with long-term follow-up of exposed children, pooling of data across cohorts and standardized approaches to analysis.

Submit a Comment

Your email address will not be published. Required fields are marked *

four × 5 =

[ HIDE/SHOW ]